In 2011, the first in a new generation of anticancer drugs called checkpoint inhibitors was approved. The drug, known as ipilimumab or Yervoy, stood apart from standard cancer treatments. It worked by ...
Please provide your email address to receive an email when new articles are posted on . First-line treatment with nivolumab-ipilimumab improved PFS and response compared with monotherapy for certain ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results